The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Fragile X Mental Retardation Protein Regulates Protein Expression and mRNA Translation of the Potassium Channel Kv4.2
Open accessAbstract
A prominent characteristic of the inherited intellectual impairment disease fragile X syndrome (FXS) is neuronal hyperexcitability, resulting in a variety of symptoms, such as hyperactivity, increased sensitivity to sensory stimuli, and a high incidence of epileptic seizures. These symptoms account for a significant part of the disease pattern, but the underlying molecular mechanisms of neuronal hyperexcitability in FXS remain poorly understood. FXS is caused by loss of expression of fragile X mental retardation protein (FMRP), which regulates synaptic protein synthesis and is a key player to limit signaling pathways downstream of metabotropic glutamate receptors 1/5 (mGlu1/5). Recent findings suggest that FMRP might also directly regulate voltage-gated potassium channels. Here, we show that total and plasma membrane protein levels of Kv4.2, the major potassium channel regulating hippocampal neuronal excitability, are reduced in the brain of an FXS mouse model. Antagonizing mGlu5 activity with 2-methyl-6-(phenylethynyl)-pyridine (MPEP) partially rescues reduced surface Kv4.2 levels in Fmr1 knock-out (KO) mice, suggesting that excess mGlu1/5 signal activity contributes to Kv4.2 dysregulation. As an additional mechanism, we show that FMRP is a positive regulator of Kv4.2 mRNA translation and protein expression and associates with Kv4.2 mRNA in vivo and in vitro . Our results suggest that absence of FMRP-mediated positive control of Kv4.2 mRNA translation, protein expression, and plasma membrane levels might contribute to excess neuronal excitability in Fmr1 KO mice, and thus imply a potential mechanism underlying FXS-associated epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, FMRP is not only involved in translational repression, it is also a translational enhancer (Bechara et al., 2009; Gross et al., 2011; Kwan et al., 2012; Tabet et al., 2016)”
From New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes (2017) · cites this paper as Gross et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting
Ehlers, M. D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00129-x · Cited by 1,096
Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
Bassell, G. J., & Warren, S. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.004 · Cited by 1,051
Self-citationCorrection of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979
Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676
Advances in the Treatment of Fragile X Syndrome
Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-0317 · Cited by 596
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.004 · Cited by 521
Muddashetty, R. S., Kelić, S., Gross, C., Xu, M., & Bassell, G. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0937-07.2007 · Cited by 421
Self-citationAntar, L. N., Afroz, R., Dictenberg, J. B., Carroll, R. C., & Bassell, G. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0099-04.2004 · Cited by 411
Self-citationStructure and Function of Kv4-Family Transient Potassium Channels
Birnbaum, S. G., Varga, A. W., Yuan, L., Anderson, A. E., Sweatt, J. D., & Schrader, L. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00039.2003 · Cited by 369
Chen, X., Yuan, L., Zhao, C., Birnbaum, S. G., Frick, A., Jung, W. E., Schwarz, T. L., Sweatt, J. D., & Johnston, D. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2667-06.2006 · Cited by 306
Cited by
Sorted by citations
Altered Neuronal and Circuit Excitability in Fragile X Syndrome
Contractor, A., Klyachko, V. A., & Portera‐Cailliau, C. (2015) · Neuron · doi:10.1016/j.neuron.2015.06.017 · Cited by 418
Deng, P.-Y., Rotman, Z., Blundon, J. A., Cho, Y., Cui, J., Cavalli, V., Zakharenko, S. S., & Klyachko, V. A. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.018 · Cited by 354
Lisman, J., Cooper, K., Sehgal, M., & Silva, A. J. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0076-6 · Cited by 351
Masini, E., Loi, E., Vega-Benedetti, A. F., Carta, M., Doneddu, G., Fadda, R., & Zavattari, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218290 · Cited by 310
Dysregulation and restoration of translational homeostasis in fragile X syndrome
Richter, J. D., Bassell, G. J., & Klann, E. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4001 · Cited by 275
Self-citationFallini, C., Bassell, G. J., & Rossoll, W. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds205 · Cited by 247
Self-citationFragile X mental retardation protein and synaptic plasticity
Sidorov, M. S., Auerbach, B. D., & Bear, M. F. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-15 · Cited by 255
The Unstable Repeats—Three Evolving Faces of Neurological Disease
Nelson, D. L., Orr, H. T., & Warren, S. T. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.022 · Cited by 207
Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins
Lugo, J. N., Smith, G. D., Arbuckle, E. P., White, J., Holley, A. J., Floruta, C. M., Ahmed, N., Gomez, M. C., & Okonkwo, O. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00027 · Cited by 162
Maurin, T., Lebrigand, K., Castagnola, S., Paquet, A. C., Jarjat, M., Popa, A., Grossi, M., Rage, F., & Bardoni, B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky267 · Cited by 163
Lee, H. Y., Ge, W., Huang, W. C., He, Y., Wang, G. X., Rowson-Baldwin, A., Smith, S. J., Jan, Y. N., & Jan, L. Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.033 · Cited by 153
Hall, A., Throesch, B. T., Buckingham, S. C., Markwardt, S. J., Peng, Y., Wang, Q., Hoffman, D., & Roberson, E. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2552-14.2015 · Cited by 152
Deng, P., Sojka, D., & Klyachko, V. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2021-11.2011 · Cited by 139
Myrick, L. K., Deng, P.-Y., Hashimoto, H., Oh, Y. M., Cho, Y., Poidevin, M. J., Suhl, J. A., Visootsak, J., Cavalli, V., Jin, P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423094112 · Cited by 133
Channelopathy pathogenesis in autism spectrum disorders
Schmunk, G., & Gargus, J. J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00222 · Cited by 126
Of Men and Mice: Modeling the Fragile X Syndrome
Dahlhaus, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00041 · Cited by 133
Multifarious Functions of the Fragile X Mental Retardation Protein
Davis, J. K., & Broadie, K. S. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.07.008 · Cited by 118
FoxP1 orchestration of ASD-relevant signaling pathways in the striatum
Araujo, D. J., Anderson, A. G., Berto, S., Runnels, W., Harper, M., Ammanuel, S., Rieger, M. A., Huang, H.-C., Rajkovich, K., Loerwald, K. W., et al. (2015) · Genes & Development · doi:10.1101/gad.267989.115 · Cited by 111
Fragile X Syndrome: from molecular pathology to therapy
Maurin, T., Zongaro, S., & Bardoni, B. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.006 · Cited by 113
Brager, D. H., Akhavan, A. R., & Johnston, D. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.02.002 · Cited by 110
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
Gross, C., Hoffmann, A., Bassell, G. J., & Berry-Kravis, E. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0355-9 · Cited by 105
Self-citationTherapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond
Groß, C., Berry‐Kravis, E., & Bassell, G. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.137 · Cited by 109
Self-citationChannelopathies in fragile X syndrome
Deng, P., & Klyachko, V. A. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00445-9 · Cited by 112
Delayed myelination in a mouse model of fragile X syndrome
Pacey, L. K. K., Xuan, I. C. Y., Guan, S. A., Sussman, D., Henkelman, R. M., Chen, Y., Thomsen, C., & Hampson, D. R. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt246 · Cited by 105
MicroRNA-Mediated Downregulation of the Potassium Channel Kv4.2 Contributes to Seizure Onset
Groß, C., Yao, X., Engel, T., Tiwari, D., Xing, L., Rowley, S. D., Danielson, S. W., Thomas, K. T., Jimenez-Mateos, E. M., Schroeder, L. M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.074 · Cited by 92
Self-citationKalmbach, B. E., Johnston, D., & Brager, D. H. (2015) · eNeuro · doi:10.1523/eneuro.0114-15.2015 · Cited by 83
Lovelace, J. W., Rais, M., Palacios, A. R., Shuai, X. S., Bishay, S., Popa, O., Pirbhoy, P. S., Binder, D. K., Nelson, D. L., Ethell, I. M., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz141 · Cited by 82
New pathologic mechanisms in nucleotide repeat expansion disorders
Rodriguez, C. M., & Todd, P. K. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104515 · Cited by 82
Deng, P., & Klyachko, V. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.046 · Cited by 79
mTOR and MAPK: from localized translation control to epilepsy
Pernice, H. F., Schieweck, R., Kiebler, M. A., & Popper, B. (2016) · BMC Neuroscience · doi:10.1186/s12868-016-0308-1 · Cited by 81
Fragile X mental retardation protein controls ion channel expression and activity
Ferron, L. (2016) · The Journal of Physiology · doi:10.1113/jp270675 · Cited by 80
Routh, B. N., Johnston, D., & Brager, D. H. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3256-13.2013 · Cited by 74
Deng, P., & Klyachko, V. A. (2015) · The Journal of Physiology · doi:10.1113/jp271031 · Cited by 73
Yang, Y., Arsenault, J., Bah, A., Krzeminski, M., Fekete, Á., Chao, O. Y.-H., Pacey, L. K. K., Wang, A. B., Forman-Kay, J. D., Hampson, D. R., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0240-0 · Cited by 72
Talbot, Z. N., Sparks, F. T., Dvořák, D., Curran, B. M., Alarcón, J. M., & Fenton, A. A. (2018) · Neuron · doi:10.1016/j.neuron.2017.12.043 · Cited by 70
Channelopathies and dendritic dysfunction in fragile X syndrome
Brager, D. H., & Johnston, D. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.01.002 · Cited by 65
Deng, P., Carlin, D., Oh, Y. M., Myrick, L. K., Warren, S. T., Cavalli, V., & Klyachko, V. A. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1593-18.2018 · Cited by 60
Martin, H. G. S., Lassalle, O., Brown, J. T., & Manzoni, O. J. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv031 · Cited by 63
Sundberg, M., Pinson, H., Smith, R. S., Winden, K. D., Venugopal, P., Tai, D. J. C., Gusella, J. F., Talkowski, M. E., Walsh, C. A., Tegmark, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23113-z · Cited by 57
Abekhoukh, S., Sahin, H. B., Grossi, M., Zongaro, S., Maurin, T., Madrigal, I., Kazue-Sugioka, D., Raas-Rothschild, A., Doulazmi, M., Carrera, P., et al. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.025809 · Cited by 59
“Indeed, FMRP is not only involved in translational repression, it is also a translational enhancer (Bechara et al., 2009; Gross et al., 2011; Kwan et al., 2012; Tabet et al., 2016) and a translation-independent function was also described for FMRP (Myrick et al., 2015).”
Hyperexcitability and homeostasis in fragile X Syndrome.
Liu, X., Kumar, V., Tsai, N.-P., & Auerbach, B. D. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.805929 · Cited by 53
Kraan, C. M., Hocking, D. R., Bradshaw, J. L., Fielding, J., Cohen, J., Georgiou‐Karistianis, N., & Cornish, K. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.010 · Cited by 53
Homeostatic Intrinsic Plasticity Is Functionally Altered in Fmr1 KO Cortical Neurons
Bülow, P., Murphy, T. J., Bassell, G. J., & Wenner, P. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.035 · Cited by 50
Self-citationIntergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism
Rivell, A., & Mattson, M. P. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.08.006 · Cited by 50
The sodium-activated potassium channel Slack is required for optimal cognitive flexibility in micePreprint
Bausch, A. E., Dieter, R., Nann, Y., Hausmann, M., Meyerdierks, N., Kaczmarek, L. K., Ruth, P., & Łukowski, R. (2015) · Learning & Memory · doi:10.1101/lm.037820.114 · Cited by 51
Bonaccorso, C. M., Spatuzza, M., Di Marco, B., Gloria, A., Barrancotto, G., Cupo, A., Musumeci, S. A., D'Antoni, S., Bardoni, B., & Catania, M. V. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.02.004 · Cited by 52
Carrasquillo, Y., & Nerbonne, J. M. (2013) · The Neuroscientist · doi:10.1177/1073858413504003 · Cited by 47
From FMRP Function to Potential Therapies for Fragile X Syndrome
Sethna, F., Moon, C., & Wang, H. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1229-3 · Cited by 49
Activity-dependent isomerization of Kv4.2 by Pin1 regulates cognitive flexibility
Hu, J., Malloy, C., Tabor, G. T., Gutzmann, J. J., Liu, Y., Abebe, D. T., Karlsson, R., Durell, S. R., Cameron, H. A., & Hoffman, D. A. (2020) · Nature Communications · doi:10.1038/s41467-020-15390-x · Cited by 47
Transient Potassium Channels: Therapeutic Targets for Brain Disorders
Noh, W., Pak, S., Choi, G., Yang, S., & Yang, S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00265 · Cited by 47
Dendritic protein synthesis in the normal and diseased brain
Swanger, S. A., & Bassell, G. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.003 · Cited by 51
Self-citationEtiology of a genetically complex seizure disorder in Celf4 mutant mice
Wagnon, J. L., Mahaffey, C. L., Sun, W., Yang, Y., Chao, H.-T., & Frankel, W. N. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00717.x · Cited by 46
Boone, C. E., Davoudi, H., Harrold, J. B., & Foster, D. J. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.05.012 · Cited by 45
Fleming, M. R., Brown, M. R., Kronengold, J., Zhang, Y., Jenkins, D. P., Barcia, G., Nabbout, R., Bausch, A. E., Ruth, P., Łukowski, R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.024 · Cited by 41
Lee, K. Y., Jewett, K. A., Chung, H. J., & Tsai, N. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy189 · Cited by 41
Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons
Graef, J. D., Wu, H., Ng, C., Sun, C., Villegas, V., Qadir, D., Jesseman, K., Warren, S. T., Jaenisch, R., Cacace, A. M., et al. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14660 · Cited by 42
Bataveljic, D., Pivonkova, H., de Concini, V., Hébert, B., Ezan, P., Briault, S., Bemelmans, A.-P., Pichon, J., Menuet, A., & Rouach, N. (2024) · Nature Communications · doi:10.1038/s41467-024-47681-y · Cited by 40
Potassium channels and autism spectrum disorder: An overview
Cheng, P., Qiu, Z., & Du, Y. (2021) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10123 · Cited by 40
Kalinowska, M., van der Lei, M. B., Kitiashvili, M., Mamcarz, M., Oliveira, M. M., Longo, F., & Klann, E. (2021) · Molecular Autism · doi:10.1186/s13229-022-00509-2 · Cited by 39
Doll, C. A., & Broadie, K. S. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.006 · Cited by 39
Imbalance of synaptic actin dynamics as a key to fragile X syndrome?
Michaelsen‐Preusse, K., Feuge, J., & Körte, M. (2018) · The Journal of Physiology · doi:10.1113/jp275571 · Cited by 36
Donlin-Asp, P., Rossoll, W., & Bassell, G. J. (2017) · FEBS Letters · doi:10.1002/1873-3468.12621 · Cited by 38
Self-citationFMRP regulates actin filament organization via the armadillo protein p0071
Nolze, A., Schneider, J., Keil, R., Lederer, M., Hüttelmaier, S., Kessels, M. M., Qualmann, B., & Hatzfeld, M. (2013) · RNA · doi:10.1261/rna.037945.112 · Cited by 35
Fragile X Syndrome: Psychiatric Manifestations, Assessment and Emerging Therapies
Wadell, P. M., Hagerman, R. J., & Hessl, D. R. (2013) · Current Psychiatry Reviews · doi:10.2174/157340013805289644 · Cited by 35
Excitability is increased in hippocampal CA1 pyramidal cells of Fmr1 knockout mice
Luque, M. A., Beltrán‐Matas, P., Marin, M. C., Torres, B., & Herrero, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185067 · Cited by 32
Epilepsy in four genetically determined syndromes of intellectual disability
Leung, H. T. T., & RING, H. A. (2011) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2011.01505.x · Cited by 31
New Insights Into the Role of Cav2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons
Castagnola, S., Delhaye, S., Folci, A., Paquet, A. C., Brau, F., Duprat, F., Jarjat, M., Grossi, M., Béal, M., Martin, S., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00342 · Cited by 30
Ohashi, R., & Shiina, N. (2020) · Biomolecules · doi:10.3390/biom10020167 · Cited by 33
Das Sharma, S., Pal, R., Reddy, B. K., Selvaraj, B. T., Raj, N., Samaga, K. K., Srinivasan, D. J., Ornelas, L., Sareen, D., Livesey, M. R., et al. (2020) · Molecular Autism · doi:10.1186/s13229-020-00351-4 · Cited by 28
Self-citationTiwari, D., Schaefer, T. L., Schroeder, L. M., Krzeski, J. C., Bunk, A. T., Parkins, E. V., Snider, A., Danzer, R., Williams, M. T., Vorhees, C. V., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113437 · Cited by 24
Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes
Wang, H., Pati, S. B. B., Pozzo‐Miller, L. D., & Doering, L. C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00055 · Cited by 28
Fragile X Mental Retardation Protein: To Be or Not to Be a Translational Enhancer
Maurin, T., & Bardoni, B. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00113 · Cited by 28
Maurin, T., Melko, M., Abekhoukh, S., Khalfallah, O., Davidovic, L., Jarjat, M., D’Antoni, S., Catania, M. V., Moine, H., Bechara, E., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv801 · Cited by 27
Gabriel, L. R., Lvov, A., Orthodoxou, D., Rittenhouse, A. R., Kobertz, W. R., & Melikian, H. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.391458 · Cited by 24
Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson’s disease
Tan, Y., Sgobio, C., Arzberger, T., Machleid, F., Tang, Q., Findeis, E., Tost, J., Chakroun, T., Gao, P., Höllerhage, M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02099-5 · Cited by 24
Murphy, J. G., Gutzmann, J. J., Lin, L., Hu, J., Petralia, R. S., Wang, Y., & Hoffman, D. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110264 · Cited by 22
Advances in understanding fragile X syndrome and related disorders
Rooms, L., & Kooy, R. F. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834c7f1a · Cited by 22
Ubiquitination and E3 Ubiquitin Ligases in Rare Neurological Diseases with Comorbid Epilepsy
Zhu, J., & Tsai, N. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2019.12.030 · Cited by 24
Gutzmann, J. J., Lin, L., & Hoffman, D. A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00027 · Cited by 21
Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome
Gray, E. E., Murphy, J. G., Liu, Y., Trang, I., Tabor, G. T., Lin, L., & Hoffman, D. A. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1443-17.2019 · Cited by 21
Kim, E., & Hoffman, D. A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2373-12.2012 · Cited by 21
The Shaping of Two Distinct Dendritic Spikes by A-Type Voltage-Gated K+ Channels
Yang, S., Tang, C., & Yang, S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00469 · Cited by 20
A single early-life seizure results in long-term behavioral changes in the adult Fmr1 knockout mouse
Hodges, S. L., Reynolds, C. D., Nolan, S. O., Huebschman, J. L., Okoh, J. T., Binder, M. S., & Lugo, J. N. (2019) · Epilepsy Research · doi:10.1016/j.eplepsyres.2019.106193 · Cited by 25
Aberrant Dendritic Excitability: A Common Pathophysiology in CNS Disorders Affecting Memory?
Nestor, M. W., & Hoffman, D. A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8265-x · Cited by 20
Increasing our understanding of human cognition through the study of fragile X syndrome
Cook, D., Nuro, E., & Murai, K. K. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22096 · Cited by 22
Involvement of FMRP in Primary MicroRNA Processing via Enhancing Drosha Translation
Wan, R.-P., Zhou, L., Yang, H., Zhou, Y., Ye, S.-H., Zhao, Q.-H., Gao, M., Liao, W., Yi, Y., & Long, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9855-9 · Cited by 20
Ordemann, G. J., Apgar, C. J., Chitwood, R. A., & Brager, D. H. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0082-21.2021 · Cited by 19
Mechanisms Driving the Emergence of Neuronal Hyperexcitability in Fragile X Syndrome
Bülow, P., Segal, M., & Bassell, G. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116315 · Cited by 22
Self-citationRescue of Fmr1 phenotypes with mGluR5 inhibitors: MRZ-8456 versus AFQ-056
Westmark, P. R., Dekundy, A., Gravius, A., Danysz, W., & Westmark, C. J. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.008 · Cited by 22
Fragile X Mental Retardation Protein expression in the retina is regulated by light
Guimarães‐Souza, E. M., Perche, O., Morgans, C. W., Duvoisin, R. M., & Calaza, K. D. C. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.11.025 · Cited by 19
Colvin, S. M., & Kwan, K. Y. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00239 · Cited by 17
Spencer, K. B., Mulholland, P. J., & Chandler, L. J. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13060 · Cited by 17
Mechanisms regulating input-output function and plasticity of neurons in the absence of FMRP
Booker, S. A., & Kind, P. C. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.06.025 · Cited by 16
Neurodevelopment and early pharmacological interventions in Fragile X Syndrome
Milla, L. A., López‐Corral, L., Rivera, J., Zúñiga, N., Pino, G., Nunez-Parra, A., & Rio, C. A. C.-D. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1213410 · Cited by 15
Dysregulation and restoration of homeostatic network plasticity in fragile X syndrome mice
Jewett, K. A., Lee, K. Y., Eagleman, D. E., Soriano, S., & Tsai, N. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.011 · Cited by 15
Intellectual disabilities, neuronal posttranscriptional RNA metabolism, and RNA-binding proteins
Bardoni, B., Abekhoukh, S., Zongaro, S., & Melko, M. (2012) · Progress in brain research · doi:10.1016/b978-0-444-54299-1.00003-0 · Cited by 15
Turning up translation in fragile X syndrome
Aryal, S., & Klann, E. (2018) · Science · doi:10.1126/science.aau6450 · Cited by 12
Liu, D.-C., Lee, K. Y., Lizarazo, S., Cook, J. K., & Tsai, N. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105450 · Cited by 15
mTOR referees memory and disease through mRNA repression and competition
Raab‐Graham, K. F., & Niere, F. (2017) · FEBS Letters · doi:10.1002/1873-3468.12675 · Cited by 13
Nolan, S. O., Jefferson, T. S., Reynolds, C. D., Smith, G. D., Holley, A. J., Hodges, S. L., & Lugo, J. N. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001241 · Cited by 13
Metadata
- Authors
- Gross, C., Yao, X., Pong, D. L., Jeromin, A., & Bassell, G. J.
- Affiliations
- Emory University (US)
- Banyan Biomarkers (United States) (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2011-04-13
- Volume
- 31
- Issue
- 15
- Pages
- 5693-5698
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC3089949
- OpenAlex
- W1992696632
- Cited by
- 161
- References
- 26
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 11 · 2019: 18 · 2018: 14 · 2017: 8 · 2016: 10 · 2015: 18 · 2014: 8 · 2013: 14 · 2012: 9
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH085617, MH085617)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD024064)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- fragile X syndrome, FMRP, Kv4.2, voltage-gated potassium channels, neuronal hyperexcitability, MPEP, mRNA translation regulation, protein expression regulation, Fmr1 knockout mice, hippocampal excitability
- MeSH terms
- Actins, Animals, Dendrites, Fluorescent Antibody Technique, Mice, Inbred C57BL, Phenotype, Polyribosomes, RNA, Messenger, Seizures, Synapses, Protein Biosynthesis, Blotting, Western, DNA Primers, Receptors, Metabotropic Glutamate, Mice, Knockout, Biotinylation, 5' Untranslated Regions, 3' Untranslated Regions, Immunoprecipitation, Mice, Shal Potassium Channels, Fragile X Messenger Ribonucleoprotein 1, Fragile X Mental Retardation Protein, Receptor, Metabotropic Glutamate 5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review